LONZA N (LONN.SW) Financials
LONN.SW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-06-30 | 17.7 billion | 7.3 billion |
| 2023-03-31 | 4.1 billion | 1.7 billion |
| 2022-12-31 | 17.4 billion | 6.7 billion |
LONN.SW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-06-30 | ? | ? |
| 2023-03-31 | -31.0 million | 11.3 million |
| 2022-12-31 | ? | ? |
LONN.SW Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 122.0 million |
| 2023-06-30 | 205.0 million |
| 2023-03-31 | 736.8 million |
| 2022-12-31 | 361.5 million |
LONN.SW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-06-30 | 2.1 billion | 2.5 billion | - |
| 2023-03-31 | 796.0 million | - | - |
| 2022-12-31 | 2.2 billion | 1.6 billion | 355.0 million |
LONN.SW Shares Outstanding
LONN.SW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-06-30 | 765.0 million | - | - | - |
| 2023-03-31 | 335.3 million | 22.5 million | 188.5 million | 56.0 million |
| 2022-12-31 | 492.5 million | 22.5 million | 188.5 million | 56.0 million |
LONN.SW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-06-30 | 3.1 billion | 2.0 billion |
| 2023-03-31 | 1.4 billion | 824.8 million |
| 2022-12-31 | 1.4 billion | 824.8 million |
LONN.SW
Price: CHF527.80
Dividend Yield: 0.01%
Forward Dividend Yield: 0.38%
Payout Ratio: 13.15%
Dividend Per Share: 2.00 CHF
Earnings Per Share: 15.21 CHF
P/E Ratio: 28.30
Exchange: EBS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 178146
Market Capitalization: 40.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 25
DGR3: 8.59%
DGR5: -4.85%
DGR10: 1.00%
DGR20: 1.67%